Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
A Bull Market Is (Still) Coming: Here Are 3 Spectacular Stocks to Buy Sooner Rather Than Later
05:52am, Sunday, 10'th Sep 2023
Amazon should deliver strong growth over the short term and long term. Mastercard's moat and growth opportunities make it an attractive pick.
1 Top Pharma Growth Stock to Buy Today and Hold Forever
10:15am, Friday, 08'th Sep 2023
Vertex Pharmaceuticals has many avenues for chasing growth both big and small. Its cystic fibrosis medicines continue to remain a rock-solid base of revenue.
2 Top Biotech Stocks to Buy in September
09:53am, Friday, 08'th Sep 2023
Vertex and Regeneron have delivered solid financial results and stock market performance. Both biotechs have exciting pipelines that should produce key new approvals or label expansions.
Could These Be Vertex Pharmaceuticals' Most Promising Candidates?
08:45am, Friday, 08'th Sep 2023
Vertex Pharmaceuticals is trying to replicate its winning cystic fibrosis formula in other areas. These efforts could yield even better financial results than its potential gene-editing therapy.
September Rally? 3 Stocks to Buy Before Liftoff
06:00am, Friday, 08'th Sep 2023
September is not known as a good month to buy stocks. In fact, historically it's the worst month.
3 Must-Know Tricks for Investing in Big Pharma Stocks
05:46am, Friday, 08'th Sep 2023
Pharma companies often have detailed plans for when new revenue will occur. They also sometimes describe periods when sales will be shrinking.
3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains
06:35pm, Tuesday, 05'th Sep 2023
In the grand tapestry of the investment world, one thread that continues to shine is biotech stocks to buy and hold. It's no secret that delving into biotech investments can be incredibly challenging,
The 3 Best Biotech Stocks to Buy Now: September 2023
03:43pm, Monday, 04'th Sep 2023
Biotech stocks have underperformed in the U.S. stock market by a wide margin this year. The sector's most popular index, the iShares Biotechnology ETF (NASDAQ: IBB ), is down 5% since Jan. 27.
2 Spectacular Growth Stocks You Can Buy in September With No Hesitation
05:50am, Sunday, 03'rd Sep 2023
D.R. Horton is a Warren Buffett stock that's a bargain and has great growth potential. Vertex Pharmaceuticals has multiple growth drivers that could make it an even bigger winner than it already is.
As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs
11:30am, Friday, 01'st Sep 2023
As Medicare's years-long drug-price negotiation process is being hotly debated and litigated, some states are plowing ahead with wide-ranging efforts to bring down costs for a potentially much broader
The 3 Most Promising Biotech Stocks to Own Now
05:42am, Thursday, 31'st Aug 2023
Despite polls showing most Americans are unhappy with the state of the economy, President Biden has defended his policies with claims he is improving the finances and living standards of minority vote
Got $600? Here are 3 No-Brainer Stocks You Absolutely Must Buy
04:17pm, Thursday, 24'th Aug 2023
The stock market recovered nicely from last year's debacle. The Nasdaq Composite Index in particular went from a 34% loss in 2022 to a 29% gain so far this year.
3 Strong Biotech Performers To Watch As Sector Nears Breakout
07:16am, Thursday, 17'th Aug 2023
The biotech sector, iShares Biotechnology ETF NASDAQ: IBB, has been trading in a tight consolidation for several months. The ETF has a 50-day range of $124.38 and $131.81.
Vertex Pharmaceuticals Still Looks Attractive
04:55am, Sunday, 13'th Aug 2023
Vertex Pharmaceuticals' Q2 financials showed strong revenue growth. The company's core portfolio of drugs for cystic fibrosis treatment has additional market opportunities. Also, Vertex has some under
Could Vertex Pharmaceuticals Stock Help You Become a Millionaire?
06:40am, Thursday, 10'th Aug 2023
Vertex Pharmaceuticals is a leader in cystic fibrosis treatments. The company is working on expanding its business, which will open up more growth opportunities.
